Tech Center 1600 • Art Units: 1682 1683
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17640016 | CRISPR EFFECTOR SYSTEM BASED MULTIPLEX CANCER DIAGNOSTICS | Non-Final OA | DANA-FARBER CANCER INSTITUTE, INC. |
| 17555945 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING | Non-Final OA | Illumina Cambridge Limited |
| 17786473 | METHOD OF MEASURING CELL-FREE DNA IN SURGICAL DRAIN FLUID TO SELECT ADJUVANT THERAPY | Non-Final OA | Washington University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy